期刊文献+

临床药师参与2例新型冠状病毒肺炎患者临床治疗的药学监护及其体会

Pharmaceutical Care for Clinical Medication in 2 Patients with COVID-19 and Their Experience
下载PDF
导出
摘要 目的:通过参与新型冠状病毒肺炎(COVID-19)患者的药物治疗实践,探究临床药师在COVID-19患者临床药物治疗中的作用。方法:临床药师参与2例COVID-19患者的临床治疗,并结合患者治疗期间药物不良反应、病情变化及"诊疗指南",协助临床医师调整治疗方案,监护用药全过程。结果:临床药师参与临床治疗和全过程的药学监护后,2例患者均治愈出院。结论:临床药师以药物使用方法、用药教育及不良反应监测为切入点,为COVID-19患者实施药学监护,促进了临床合理用药,确保了患者用药的安全性和有效性。 Objective:To investigate the role of the clinical pharmacists in the therapy for patients with COVID-19 through the practice of clinical medication.Methods:The clinical pharmacists participated in the clinical medication of 2 patients with COVID-19,assisted the clinician to adjust the treatment plan and monitored the whole process of medication based on the adverse drug reactions,changes in the patient’s condition and"diagnosis and treatment guidelines".Results:Both patients were cured and discharged after the clinical pharmacist participated in the clinical medication and the whole process of pharmaceutical care.Conclusion:Clinical pharmacists implemented pharmaceutical care for COVID-19 patients by taking medication use methods,medication education and adverse reaction monitoring as entry points,which promoted rational clinical medication and ensured the safety and efficacy of medication.
作者 吴庆荣 王元春 陈艳婷 宋晓兵 WU Qing-rong;WANG Yuan-chun;CHEN Yan-ting;SONG Xiao-bing(Ganzhou No.5 People’s Hospital Affiliated to Gannan Medical College,Ganzhou Jiangxi 341000,China;Guangzhou University of Traditional Chinese Medicine,Guangzhou 510000,China)
出处 《抗感染药学》 2020年第7期1080-1084,共5页 Anti-infection Pharmacy
基金 赣州市科技计划(编号:GZ2017ZSF286)。
关键词 新型冠状病毒肺炎 COVID-19 药学监护 合理用药 novel coronavirus pneumonia COVID-19 pharmaceutical care rational drug use
  • 相关文献

参考文献16

二级参考文献191

共引文献464

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部